Stocks and Investing
Stocks and Investing
Wed, October 13, 2021
[ Wed, Oct 13th 2021
] - WOPRAI
[ Wed, Oct 13th 2021
] - WOPRAI
[ Wed, Oct 13th 2021
] - WOPRAI
[ Wed, Oct 13th 2021
] - WOPRAI
[ Wed, Oct 13th 2021
] - WOPRAI
[ Wed, Oct 13th 2021
] - WOPRAI
[ Wed, Oct 13th 2021
] - WOPRAI
[ Wed, Oct 13th 2021
] - WOPRAI
[ Wed, Oct 13th 2021
] - WOPRAI
[ Wed, Oct 13th 2021
] - WOPRAI
[ Wed, Oct 13th 2021
] - WOPRAI
[ Wed, Oct 13th 2021
] - WOPRAI
[ Wed, Oct 13th 2021
] - WOPRAI
[ Wed, Oct 13th 2021
] - WOPRAI
[ Wed, Oct 13th 2021
] - WOPRAI
[ Wed, Oct 13th 2021
] - WOPRAI
[ Wed, Oct 13th 2021
] - WOPRAI
[ Wed, Oct 13th 2021
] - WOPRAI
[ Wed, Oct 13th 2021
] - WOPRAI
[ Wed, Oct 13th 2021
] - WOPRAI
[ Wed, Oct 13th 2021
] - WOPRAI
[ Wed, Oct 13th 2021
] - WOPRAI
[ Wed, Oct 13th 2021
] - WOPRAI
[ Wed, Oct 13th 2021
] - WOPRAI
[ Wed, Oct 13th 2021
] - WOPRAI
[ Wed, Oct 13th 2021
] - WOPRAI
Tue, October 12, 2021
[ Tue, Oct 12th 2021
] - WOPRAI
[ Tue, Oct 12th 2021
] - WOPRAI
[ Tue, Oct 12th 2021
] - WOPRAI
Rebecca Liang Initiated (BGNE) at Buy and Held Target at $431 on, Oct 12th, 2021
Rebecca Liang of Bernstein, Initiated "BeiGene, Ltd." (BGNE) at Buy and Held Target at $431 on, Oct 12th, 2021.
Rebecca has made no other calls on BGNE in the last 4 months.
There are 2 other peers that have a rating on BGNE. Out of the 2 peers that are also analyzing BGNE, 0 agree with Rebecca's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Rebecca
- Matthew Harrison of "Morgan Stanley" Maintained at Buy with Decreased Target to $407 on, Monday, August 16th, 2021
- Andrew Berens of "SVB Leerink" Maintained at Buy with Increased Target to $417 on, Monday, June 14th, 2021
Contributing Sources